STRADIVARIUS Effect of Rimonabant on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease Stephen J. Nicholls.
CHARISMA Genomics Deepak L. Bhatt MD, MPH, Katy L. Simonsen PhD, Eileen S. Emison PhD, Keith A. A. Fox MBChB, P. Gabriel Steg MD, Gilles Montalescot MD,
Combined Use of Oral Antiplatelet Agents and Gastroprotective Agents: Focus on PPIs and Clopidogrel Combined Use of Oral Antiplatelet Agents and Gastroprotective.
CHARISMA: The “CAPRIE-like” Cohort Deepak L. Bhatt MD, FACC, FSCAI, FESC, FACP Associate Director, Cleveland Clinic Cardiovascular Coordinating Center.
The COGENT Trial Deepak L. Bhatt MD, MPH, Byron Cryer MD, Charles F. Contant PhD, Marc Cohen MD, Angel Lanas MD, DSc, Thomas J. Schnitzer MD, PhD, Thomas.
Deepak L. Bhatt MD, MPH, FACC, FAHA Chief of Cardiology, VA Boston Healthcare System
The Safety and Tolerability of Atopaxar (E5555) in the Treatment of Patients with Acute Coronary Syndromes: The LANCELOT-ACS Trial Michelle O’Donoghue.
